How integration of global omics-data could help preparing for pandemics â€“ a scent of influenza by Lieuwe D. J. Bos et al.
PERSPECTIVE ARTICLE
published: 22 April 2014
doi: 10.3389/fgene.2014.00080
How integration of global omics-data could help preparing
for pandemics – a scent of inﬂuenza
Lieuwe D. J. Bos1,2,3*, Menno D. de Jong4, Peter J. Sterk 2 and Marcus J. Schultz1,3
1 Department of Intensive Care Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
2 Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
3 Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
4 Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
Edited by:
Pietro Lio, University of Cambridge,
UK
Reviewed by:
Julio Vera González, University
Hospital Erlangen, Germany
Anatoly Sorokin, Russian Academy of
Sciences, Russia
*Correspondence:
Lieuwe D. J. Bos, Department of
Intensive Care Medicine, Academic
Medical Center, University of
Amsterdam, G3–228, Meibergdreef 9,
1105 AZ Amsterdam, Netherlands
e-mail: l.d.bos@amc.uva.nl
Pandemics caused by novel emerging or re-emerging infectious diseases could lead to
high mortality and morbidity world-wide when left uncontrolled. In this perspective, we
evaluate the possibility of integration of global omics-data in order to timely prepare for
pandemics. Such an approach requires two major innovations. First, data that is obtained
should be shared with the global community instantly. The strength of rapid integration of
simple signals is exempliﬁed by Google’sTM FluTrend, which could predict the incidence of
inﬂuenza-like illness based on online search engine queries. Second, omics technologies
need to be fast and high-throughput. We postulate that analysis of the exhaled breath
would be a simple, rapid and non-invasive alternative. Breath contains hundreds of volatile
organic compounds that are altered by infection and inﬂammation.Themolecular ﬁngerprint
of breath (breathprint) can be obtained using an electronic nose, which relies on sensor
technology. These breathprints can be stored in an online database (a “breathcloud”) and
coupled to clinical data. Comparison of the breathprint of a suspected subject to the
breathcloud allows for a rapid decision on the presence or absence of a pathogen.
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RATIONALE
Respiratory tract infections are the primary cause of death by
communicable diseases (Lopez et al., 2006). The global burden
is estimated to be around 3.7 million deaths yearly. Novel emerg-
ing or re-emerging infectious diseases could increase the number
of victims substantially, as exempliﬁed by the approximately
50 million deaths in the Spanish inﬂuenza pandemic in 1918–
1919 (Taubenberger and Morens, 2006). Subsequent inﬂuenza
pandemics and the emergence of novel animal-origin inﬂuenza
(H5N1, H7N9) and coronaviruses (SARS-CoV, MERS-CoV) that
cause severe infections in humans illustrate a continuous and
ongoing threat of new pandemics. Intensive farming and chang-
ing climate enhance the likelihood of (zoonotic) transmission of
animal-origin pathogens to humans and subsequent evolution
of such pathogens to efﬁcient infection of – and transmission
between humans. Globalization,migrations and intensive tourism
further increase the chance of rapid spread of such agents (Jones
et al., 2008).
Since infectious disease outbreaks typically emerge unexpect-
edly and can advance swiftly, rapid detection of (re)-emerging
pathogens is of utmost importance. Rapid detection allows for
optimal preparation on the level of individuals (e.g., early recogni-
tion, quarantine and swift start of adequate treatment of individual
patients), on the level of populations (e.g., fast vaccination and
other preventive measures), and on the level of organizations
(e.g., timely preparation and education of hospital personnel,
adequate distribution of therapeutics and medical equipment,
and preparation of research infrastructures), thereby hopefully
limiting burden caused by each novel rapidly spreading disease.
The two most important challenges are timely recognition of
infected individuals and sufﬁcient and timelymonitoring of global
spread of an outbreak. The ﬁrst step to optimal preparation may
therefore be earlier recognition of infected individuals and global
availability of data on spread of outbreaks. In this perspective, we
describe a novel vision of how pandemics could be monitored in
the future, using global omics-data. We will use inﬂuenza as an
example as this has been an important causative infection in the
past and is likely to cause successive pandemics in the near future.
THE STATE OF THE ART FOR INFLUENZA DIAGNOSIS AND
TREATMENT
As conventional diagnostic methods such as viral culture and
detection of antigens or antibodies have limitations due to low
sensitivity and delay in time, the ofﬁcious gold standard for
laboratory diagnosis is detection of viral nucleic acids by reverse-
transcriptase polymerase chain reaction (RT-PCR; George, 2012).
Using this highly sensitive technique,minute amounts of virus can
be detected and inﬂuenza virus subtypes can be differentiated in
less than a few hours. The obvious disadvantages are that skilled
personal is needed to perform the tests and that they may not be
available during evenings, nights and weekend. This potentially
causes delay in the diagnosis of an inﬂuenza infection in indi-
vidual patients (Writing Committee of the WHO Consultation
on Clinical Aspects of Pandemic (H1N1) 2009 Inﬂuenza et al.,
2010).
Especially in case of severe illness, any delay is unwanted as
it could hamper timely and life-saving measures and treatment
(WritingCommittee of theWHOConsultationonClinicalAspects
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of Pandemic (H1N1) 2009 Inﬂuenza et al., 2010; Ryoo et al., 2013).
Of course, one could decide to quarantine and treat every critically
ill patient who presents with inﬂuenza-like symptoms empiri-
cally (Writing Committee of the WHO Consultation on Clinical
Aspects of Pandemic (H1N1) 2009 Inﬂuenza et al., 2010). Potential
side-effects of treatment and high costs associated with quaran-
tine, however, are arguments against such “unselected” treatment,
especially on a large scale.
In the scenario of a pandemic with new emerging or re-
emerging infections, every delay in adequate diagnosis halts
precautionary measures to protect the uninfected individuals.
These individuals could be vaccinated, if possible, which may
(partially) protect them against the virus when being carried
sufﬁciently ahead of time. Adequate vaccination may also limit
further spread of the virus under speciﬁc circumstances, as vacci-
nated individuals not only stay healthy but also will not become
contagious themselves. On the level of organization, timely detec-
tion allows for preparation and education of hospital personal
and distribution of therapeutics and equipment to the desired
location.
GLOBAL RECOGNITION OF FLU THROUGH INTEGRATION OF
SIGNALS
Equally important to the time to diagnostic test results is the
time to global availability of these data, especially if prepara-
tion at the population level and global organization for pandemia
prevention is a goal. A system that obliges clinicians to report
new cases of severe respiratory viral infections, called the public
health response, is available for the clinical suspicion of speciﬁc
pathogens but this requires a pro-active effort of doctors. Auto-
mated integration of test results through an online platformwould
allow for real-time surveillance. This approach is nicely illustrated
by “Flu Trend” in GoogleTM (http://www.google.org/ﬂutrends/).
Using online search engine query data such as “inﬂuenza compli-
cation” and “ﬂu remedy,” GoogleTM is able to detect epidemics of
respiratory viruses (Ginsberg et al., 2009). This method could pre-
dict the incidence of inﬂuenza-like illness 1 week before the Center
of Disease Control (Ginsberg et al., 2009). However, as the input
data for this model are not speciﬁc for inﬂuenza infection, this tool
is helpful for inﬂuenza-like illness but probably not sufﬁcient for
monitoring the spread of a speciﬁc strain of the inﬂuenza virus.
To capture this complexity, more speciﬁc viral signals should be
investigated.
SYSTEMS BIOLOGY AND “OMICS” TECHNOLOGIES
Search engine queries rely on the phenotypic presentation of
people with symptoms of inﬂuenza-like illnesses. Symptoms
are non-speciﬁc results of physiological, cellular and molecular
changes in the body that occur during viral infection. Systems
biology aims to integrate the signals from all these levels into an
understanding of the complete system (Josset et al., 2013). Fol-
lowing this philosophy, several “omics” technologies have been
developed to measure the molecular landscape in an integrative
fashion within one domain. “Genomics” can be used to study
genetic risk factors for disease susceptibility of the host (Key-
nan et al., 2013) and for understanding of the pathogenicity of
the pathogen in this context (Kash, 2009). Analysis of mRNA
using “transcriptomics” potentially allows for simultaneous mea-
surement of the expression of 10s of 1000s genes. Transcription
research allows for rapid testing (e.g., in the order of hours) and
provides more information on functionality than genomics alone.
However, proteins are ultimately responsible for the function of
cells. “Proteomics” has therefore the potential to uncover impor-
tant interactions between the virus and the host. Studies show
that inﬂuenza induces rapid changes in the host transcriptome
and proteome (Liu et al., 2012; Pommerenke et al., 2012), as soon
as 1 h after infection (Cheung et al., 2012). These very early tem-
poral changes after infection are also observed at the metabolite
level (Lin et al., 2012). “Metabolomics” is “the global assessment of
endogenous metabolites within a biologic system and represents a
snapshot-reading of gene function, enzyme activity and the phys-
iological landscape” (Serkova et al., 2011). Treatment of inﬂuenza
inducesmanymetabolic changes that can be traced back to speciﬁc
pathways (Lu et al., 2012).
“OMICS” TECHNOLOGIES FOR GLOBAL INFLUENZA
SURVEILLANCE
The systems biology approach has the potential to increase under-
standing of the spread of a pandemic and the adaptations that
viruses undergo meanwhile, as exempliﬁed recently in outstand-
ing research on the inﬂuenza virus reservoir in birds (Huang et al.,
2013). The major problem with these technologies for monitoring
is that they are very time-consuming and expensive, thus con-
clusions can only be drawn after the pandemic has ended, which
is obviously too late. As such, they may only be sufﬁcient for
research on the pathogenesis of a pathogen responsible for the
pandemic of interest. However, the unbiased approaches of sys-
temsbiology canbeused forunsupervisedprevisions about disease
spreading if this information could be obtained rapidly and at the
bedside.
FOCUS ON EXHALED BREATH
Exhaled breath of infected individuals contains aerosols ﬁlled with
inﬂuenza viruses, mostly present in coarse particles (<5 μm;
Milton et al., 2013). This in fact is an important route for the
virus to spread. Breath also contains thousands of volatile organic
compounds (VOCs), metabolites in gas-phase produced by both
physiological and pathophysiological processes (Pauling et al.,
1971; Moser et al., 2005). Pulmonary infection, inﬂammation and
oxidative stress may alter the concentration of certain VOCs in
exhaled breath (Bos et al., 2013a,b). VOC-patterns identiﬁed by
smell have been used to diagnose disease and intoxication for
ages (e.g., scent of acetone in uncontrolled diabetes; Manolis,
1983). Thus, inﬂuenza diagnosis based on exhaled breath anal-
ysis could take two forms: detection of aerosols with viral RNA, or
an inﬂuenza-speciﬁc VOC-patterns.
So far, both these methods have relied on relatively time-
consuming methods, RT-PCR and gas-chromatography coupled
to mass-spectrometry, respectively. Rapid technological innova-
tion in sensors, however, allows for detection of these signals
using re-usable, rapid and easy nanosensor arrays. For example,
a silicon nano-wire sensor device would allow inﬂuenza detec-
tion in half the time of RT-PCR in the clinical setting (Shen
et al., 2012). Devices using sensor-based detection of VOCs are
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called “electronic noses,” following their apparent similarities
to olfaction (Röck et al., 2008). Electronic noses integratively
capture complex VOC mixtures using an array of different sen-
sors (Röck et al., 2008). Sensors have individual sensitivities
and speciﬁcities for multiple VOCs. The composite signal of all
sensors can be analyzed using pattern-recognition algorithms.
Electronic nose analysis of breath results in a unique ﬁnger-
prints of exhaled metabolites, called “breath-prints.” This allows
rapid identiﬁcation, recognition and comparison of VOC mix-
tures. Thereby, these breath-prints can be used for diagnostic
and monitoring purposes, which do not require identiﬁca-
tion of individual molecular constituents. Breath-prints have
found to be different in a wide range of respiratory diseases
(Hockstein et al., 2005; Machado et al., 2005; Fens et al., 2009,
2010).
MONITORING OF MALODOR USING AN ELECTRONIC NOSE
Electronic nose technology is not sufﬁciently mature for
widespread application in clinical practice. However, we can look
at other applications to glance at the possibilities for global mon-
itoring using this technology. In the port of Rotterdam, the
Netherlands, with 10 km × 10 km one of the largest ports in
the world, odor nuisance is a major problem. 30 metal oxide
sensor based electronic noses were installed throughout the por-
tal area, to monitor odor emissions in order to timely prevent
nuisance (Bootsma and Milan, 2010; Milan et al., 2012). After a
training period in which sensors were learned to recognize “mal-
odor,” the electronic noses were able to recognize more than 90%
of the reported odor complaints in advance. Based on compar-
ison between ﬁngerprints of the recognized odor and an online
database of previous events (an“odor-cloud,” in line with the pop-
ular expression for an online virtual server application) the most
probable chemical characteristics of the scent can be estimated
(Apostulou,2012). Combinedwith the temporal ﬁndings in differ-
ent sensors and the direction and speedof thewind, themost prob-
able source of pollution canbe identiﬁed (Figure 1). This approach
has allowed for prevention of the development of odor nuisance
and environmental pollution by reﬁneries, but also passing cargo
ships.
FIGURE 1 | Odor signatures in the harbor of Rotterdam.The odor
signature disseminates in the direction of the wind leading to increased
complaints of inhabitants (telephone symbols on the ﬁgure), with
permission of Simon Bootsma.
MONITORING OF EXHALED BREATH USING ELECTRONIC
NOSES
The parallels between monitoring of the spread of malodor in
industrialized areas and of viral infections are striking. In both
situations, the timing of the event is unknown, which requires
continuous surveillance, and source identiﬁcation is necessary
for early intervention. In the case of exhaled breath analysis,
the source cannot be identiﬁed with the direction of the wind,
but by movement of hosts or patient populations. Therefore,
we postulate that exhaled breath tests can best be positioned in
places where large groups of people assemble for traveling. One
could think of airports, train stations or border control. Here,
a very sensitive test may identify infected individuals who are
to contribute to the global spread of the pathogen. Importantly,
the technique should be high-throughput and the result should
be available instantaneously. Thus, in line with environmental
surveillance, exhaled breath analysis of patients would allow for
the construction of an online database with previously observed
breath-prints (a “breath-cloud”; Figure 2). Linked with the clin-
ical characteristics of these patients, an exhaled breath pattern
for inﬂuenza infection can be identiﬁed and subsequently used
for characterization of new patients. When the clinical informa-
tion of these patients is known, the breath-cloud can be updated
and identiﬁcation can be improved, allowing for repeated, cyclic
improvement of the diagnostic algorithm. There are important
differences in the type and concentration of VOCs in environ-
mental and breath analysis. In the environment, the molecules
of interest are mostly present in parts-per-million concentra-
tion, in contrast to 10s to 100s parts-per-billion in breath. This
means that sensors for breath monitoring need to be more sen-
sitive. The VOCs of interest are mostly sulfur-containing and
cyclic compounds in studies on maladour but breath research
is not limited to those. Therefore it is anticipated that the
sensor array ought to be larger and more versatile in breath
analysis.
REQUIRED STEPS FOR INTEGRATING THE METHODOLOGY
Several steps are needed to accomplish the above-suggested
approach:
• The VOCs that can be used for early diagnosis of a viral infec-
tion need to be identiﬁed. A very sensitive diagnosis is a ﬁrst
requirement for global screening as the goal is to isolate a small
potion of the population while maintaining a very high negative
predictive value.
• An appropriate array of sensors needs to be assembled. These
arrays need to contain several sensors that are designed to
react selectively with the previously identiﬁed VOCs and a wide
variety of general, semi-selective (cross-reactive) sensors (Kon-
valina and Haick, 2013). The former are used for speciﬁc iden-
tiﬁcation of a viral infection but are prone to changes in virus
induced exhaled breath proﬁle that may occur over time, due
to viral mutations or phenotypic changes. The latter allows for
plasticity of the diagnostic algorithmby reactingwithunselected
VOCs.
• An online centralized database, were to breath-prints are
uploaded, instantly should be created. Thus, the electronic
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FIGURE 2 | Future perspective of integration of global omics signals.
There is a centralized database containing molecular ﬁngerprints of past
cases, the “breath-cloud” (middle of the picture). Green ﬁngerprints
represent suspected cases that were found to be most similar to the
non-infected proﬁle. Red ﬁngerprints represent cases that were most
similar to the infected proﬁle. There is a new suspected case in Italy,
the molecular signature is now compared to the proﬁles in the
breath-cloud.
noses should be connected to the Internet, which allows for
synchronization with the breath-cloud.
• The electronic noses should be readily available in the areas
where the ﬁrst signals of an outbreak are visible.
OTHER TECHNOLOGIES
Exhaled breath analysis by electronic nose may not be the only
technology that is continuously available and provides a direct
test result. Any technology that gives a rapid result can be used
for the same purpose. All signals can be used complementary
by uploading them together to the same online database. Here a
pattern recognition algorithm can treat these signals similar and
will select only the most discriminative, updating prior beliefs
with every additional information that becomes available. The
development of bedside PCR machines is exciting in this respect
as these could allow for very accurate and rapid detection of viral
RNA (Centers for Disease Control and Prevention, 2013). Further
miniaturization and optimization toward a “lab on a chip” will
further improve the time to result and bedside use (Sun et al.,
2011; Song et al., 2012).
CONCLUSION
To conclude, there is a need for rapid diagnosis of speciﬁc infec-
tions (including but not restricted to outbreaks of inﬂuenza),
especially during a pandemic. High-throughput chemical proﬁl-
ing of patient material could provide a fast and objective means
to diagnose patients. At this moment, portable electronic nose
technology is a good example of how these infections can be cap-
tured rapidly at the bedside and can be shared with the world
in the form of a “breath-cloud.” In principle, any technology that
provides test results rapidly could attribute to this online database.
Pattern recognition software can subsequently be used to diagnose
new suspected cases based on previous proﬁles from patients all
over the world.
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